title: HIV inactivation: time for a second look.
authors.affiliation: aPhotoImmune Biotechnology Inc bMolecular Surgeon Research Center, Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston cDepartment of Molecular Virology and Microbiology, Baylor College of Medicine, Houston dUniversity of Texas Medical School at Houston, Houston, Texas, USA.
authors.forename: Adan
authors.initials: A
authors.lastname: Rios
authors.forename: Ethan C
authors.initials: EC
authors.lastname: Poteet
authors.forename: Edward B
authors.initials: EB
authors.lastname: Siwak
authors.forename: Dallas W
authors.initials: DW
authors.lastname: Anderson
authors.forename: Qizhi C
authors.initials: QC
authors.lastname: Yao
mesh_terms: D016915:AIDS Vaccines / Q000627:therapeutic use*; D005544:Forecasting; D015658:HIV Infections / Q000517:prevention & control*; D006801:Humans; D015164:Vaccines, Inactivated / Q000627:therapeutic use*
chemical_list: D016915:AIDS Vaccines; D015164:Vaccines, Inactivated